Advertisement

Ads Placeholder
Loading...

GreenLight Biosciences Holdings

GRNAW•NASDAQ
Healthcare
Biotechnology
$0.02
$0.002(8.91%)
U.S. Market opens in 10h 45m

GreenLight Biosciences Holdings (GRNAW) Stock Overview

Explore GreenLight Biosciences Holdings’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.24
EPS (TTM)N/A
ROE-18.47%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

GRNAW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GreenLight Biosciences Holdings (GRNAW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.24 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
8.91%
3-Month Change
-15.71%
6-Month Change
-74.12%
Year-to-Date (YTD) Change
-74.12%
1-Year Change
-95.22%
3-Year Change
-98.05%
5-Year Change
-98.05%
All-Time (Max) Change
-98.05%

Contact Information

https://greenlightbiosciences.com
617 616 8188
200 Boston Avenue, Medford, MA, 02155

Company Facts

2,800 Employees
CountryUS

Frequently Asked Questions